You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

TRIMETHOBENZAMIDE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for trimethobenzamide hydrochloride and what is the scope of patent protection?

Trimethobenzamide hydrochloride is the generic ingredient in three branded drugs marketed by King Pharms Llc, Avet Lifesciences, Lupin, Sun Pharm Industries, Endo Operations, Am Regent, Hospira, Smith And Nephew, Solopak, and Watson Labs, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for trimethobenzamide hydrochloride. Ten suppliers are listed for this compound.

Summary for TRIMETHOBENZAMIDE HYDROCHLORIDE
Recent Clinical Trials for TRIMETHOBENZAMIDE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Indiana UniversityPhase 2
Kyowa KirinPhase 2
PfizerPhase 1

See all TRIMETHOBENZAMIDE HYDROCHLORIDE clinical trials

Pharmacology for TRIMETHOBENZAMIDE HYDROCHLORIDE
Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Anatomical Therapeutic Chemical (ATC) Classes for TRIMETHOBENZAMIDE HYDROCHLORIDE

US Patents and Regulatory Information for TRIMETHOBENZAMIDE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet Lifesciences TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 205950-001 Nov 21, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 086577-001 Oct 19, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 088804-001 Apr 3, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations TIGAN trimethobenzamide hydrochloride INJECTABLE;INJECTION 017530-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 091330-001 Mar 8, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
King Pharms Llc TIGAN trimethobenzamide hydrochloride CAPSULE;ORAL 017531-006 Dec 13, 2001 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE trimethobenzamide hydrochloride INJECTABLE;INJECTION 091329-001 Mar 8, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.